Danish Headache Center
Glostrup Municipality, Denmark, 2600
NCT Number: NCT02066558
In this study the investigators will research the hypothesis that the gas carbon monoxide induces headache and increases the blood flow velocity in the middle cerebral artery.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Glostrup Municipality, Denmark, 2600
To investigate headache score and accompanying symptoms during and after inhalation of carbon monoxide.
With transcranial Doppler imaging, c-scan and laser speckle the investigators will investigate changes in blood flow velocity of the middle cerebral artery (MCA), diameter of the superficial temporal artery (STA), the radial artery and facial skin perfusion.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
carbon monoxide, 4.7, Purity 99.997, inhalation of carbon monoxide in a volume corresponding to carboxyhemoglobin 10 and 20%, calculated from baseline Hg and body mass.
Time frame: 12 h
Comparison between carbon monoxide and placebo (atmospheric air)
Time frame: 0-180 min after inhalation
Carbon monoxide induced changes in blood flow velocity in the middle cerebral artery before and after inhalation.
Time frame: 0-180 min
Carbon monoxide induced changes in the superficial temporal artery and the radial artery before and after inhalation.
Time frame: 0-180 min
Carbon monoxide induced changes in facial blood flow before and after inhalation.
Danish Headache Center
Other
Basic Research on Carbon Monoxide's Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow in a Humane Experimental Headache Model
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07699549
Brain Diseases, Central Nervous System Diseases
Madrid, Spain
View Trial DetailsNCT01073787
Brain Diseases, Central Nervous System Diseases
Edmonton, Alberta, Canada
View Trial DetailsNCT03472092
Brain Diseases, Central Nervous System Diseases
Cincinnati, Ohio, United States
View Trial DetailsNCT05853900
Brain Diseases, Central Nervous System Diseases
New York, United States
View Trial Details